10-Year ASCVD Calculator

What hard ASCVD means, and what it leaves out

The pooled cohort equations from the 2013 ACC/AHA cholesterol guideline estimate the odds of a first major event over the next decade. The guideline, published in Circulation, uses the term hard ASCVD for that outcome. It covers four things: death from coronary heart disease, a nonfatal heart attack, a fatal stroke, or a nonfatal stroke.

The definition is deliberately narrower than cardiovascular disease as a whole. Angina, transient ischemic attacks, heart failure, stents, bypass surgery and peripheral artery disease are not part of the score. A person can receive an 8% ten-year score and still develop symptoms that land them in a cardiac catheterization suite next month.

Nine inputs go into the formula: age, sex, race group, total cholesterol, HDL cholesterol, systolic blood pressure, whether you take blood pressure medicine, whether you smoke, and whether you have diabetes. The math looks forward 10 years and ignores past history, because the cohorts excluded anyone who had already suffered an event.

How the math turns nine facts into one percentage

Every input is converted to a natural logarithm, multiplied by a weight from the 2013 paper, and added to a sum. Two terms couple age with cholesterol, and one couples age with smoking, so the same lab value means different things at 45 and 65. The sum is compared against the average for the cohort, exponentiated, and applied to a baseline survival rate.

Here are the steps for a 58-year-old white male with total cholesterol 220 mg/dL, HDL 42 mg/dL, untreated systolic pressure 138 mm Hg, no diabetes, and current smoking:

• Log of age 58 times 12.344 gives 50.122.
• Log of total cholesterol 220 times 11.853 gives 63.931, minus the age interaction of 58.343.
• HDL terms add -29.864 and 26.847.
• Untreated systolic pressure 138 adds 8.692.
• Smoking terms add 7.837 minus the age interaction of 7.288, netting 0.549.
• The terms add up to 61.932.
• Subtract the cohort mean of 61.180 to get 0.752.
• Raise e to the 0.752 power, which equals 2.122.
• Raise the baseline survival of 0.9144 to the 2.122 power, giving 0.8266.
• One minus 0.8266 is 17.3%.

The calculator repeats those steps every time an input changes. If this man puts out his last cigarette, the smoking terms disappear, the sum drops to 61.383, and the risk drops to 10.4%. That is 6.9 percentage points off the score from a single change.

The nine inputs, and where each one comes from

Two of the nine inputs come from a lab draw, three come from a blood pressure cuff or a medicine cabinet, and the rest are facts about you. The table below lists each one, the value used in the worked example, and where it comes from, so you can gather everything before you start typing.

Two details trip people up. The treatment question is not whether your blood pressure is controlled; it asks whether you swallow a pill for it, because treated pressure carries its own coefficient. The smoking question asks about today, not about the decade you quit ten years ago. If any value is more than a few months old, the honest move is to recheck it before trusting the output.

The four risk bands and the 7.5% statin threshold

The 2018 AHA/ACC guideline groups the 10-year score into four bands, and the treatment conversation turns on which band you sit in.

The 7.5% line is where a statin discussion becomes a guideline recommendation for adults aged 40 to 75 with LDL between 70 and 189 mg/dL. It is not an order; it is the point where the trial data show that the benefit of lowering LDL outweighs the small risk of statin side effects. For patients who sit in the intermediate band and hesitate to take a daily pill, a coronary artery calcium scan can break the tie.

How much each risk factor moves the needle

People often ask which number hurts them most. The table below takes the 58-year-old baseline case and changes one factor at a time, keeping everything else fixed.

Three patterns stand out. First, diabetes is the heaviest single modifiable factor: adding it almost doubles the risk, jumping the score from 17.3% to 30.7%. Second, ten years of aging adds 8.3 points, more than smoking contributes on this profile. Third, taking blood pressure medicine slightly increases the estimated risk at the same systolic reading; that is because treated hypertension serves as a proxy for long-standing vascular exposure, not because the pills are harmful.

Who should not use this calculator

The pooled cohort equations were designed for primary prevention in adults aged 40 to 79. Several groups fall outside that window and should not rely on this score:

• People who have already had a heart attack, stroke or stent. You are in secondary prevention, where guidelines recommend high-intensity statin therapy regardless of a percentage score.
• Anyone with LDL cholesterol of 190 mg/dL or higher. That reading flags possible familial hypercholesterolemia, and the guideline directs immediate high-intensity statin treatment without calculating a 10-year score.
• Adults younger than 40. Ten-year risk is almost always low in young adults because age carries so much weight. A 32-year-old smoker with high cholesterol might score under 2% today while building up decades of plaque; guidelines recommend lifetime risk estimation instead.
• Adults older than 79. The original cohorts had few participants over 79, so the formulas lose calibration, and nearly every senior scores in the high band purely due to age.

The Centers for Disease Control and Prevention notes that cardiovascular disease remains the leading cause of death in the United States, which is why routine screening begins at age 40 for average-risk adults.

Limits of the 2013 equations and the 2023 PREVENT update

The 2013 equations have saved lives by standardizing treatment, but cardiologists recognize several flaws. First, they overestimate risk in contemporary populations. The cohorts were enrolled decades ago, when smoking was more common and diets were different; modern validation studies show the equations often predict 20% to 50% more events than occur in practice.

Second, race is handled crudely. The formula provides only two tracks: African American and White or other. Hispanic, Asian American and Native American patients are lumped into the White model, which underestimates risk in South Asians and overestimates it in East Asians. The National Heart, Lung, and Blood Institute provides consumer guidance that highlights the role of individual ancestry and family history alongside these population scores.

In late 2023, the AHA introduced the PREVENT equations to address these gaps. PREVENT covers ages 30 to 79, removes race from the algorithm, adds kidney measures like estimated GFR and urine albumin, and includes heart failure as an outcome. PREVENT scores generally run lower than 2013 PCE scores. Because clinical guidelines and electronic health records take years to update, most primary care clinics still report the 2013 pooled cohort score shown on this page.